[n11.] Simpson DL, Rumack BH; Methylenedioxyamphetamine: Clinical description of
overdose, death, and review of pharmacology. Arch Intern Med
1981;141:1507-1509. PAGE 50
Copyright 1987 Amer. Medical Assn., JAMA, March 27, 1987
[n12.] Shulgin AT: Psychotomimetic drugs: Structure-activity relationships, in
Iversen LL, Eversen SD, Snyder SH (eds): Handbook of Psychopharmacology. New
York, Plenum Publishing Corp, 1978, vol 11, pp 243-333.
[n13.] Riedlinger JE: The scheduling of MDMA: A pharmacist's perspective. J
Psychoactive Drugs 1985;17:167-171.
[n14.] Weiner N: Norepinephrine, epinephrine, and the sympathomimetic amines, in
Gilman AG, Goodman LS, Gilman A (eds): The Pharmacological Basis of
Therapeutics. New York, MacMillan Publishing Co Inc, 1980, pp 138-175.
[n15.] Benowitz NL, Rosenberg J, Becker CE: Cardiopulmonary catastrophes in
drug-overdosed patients. Med Clin North Am 1979;63:267-296.
[n16.] Benatar SR: Fatal asthma. N Engl J Med 1986;314:423-429.
[n17.] Data From the Drug Abuse Warning Network. Series 1, No. 5. Rockville,
Md, National Institute on Drug Abuse, 1985, p 53.
GRAPHIC: Figure, Structural formulas of MDMA, MDEA, and related compounds.****------------------------------------------------------------------------****